
Ali Shields
Articles
-
May 27, 2024 |
dialnet.unirioja.es | Ali Shields |April Armstrong |Manraj Kaur |Alison M. Layton
Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with AcneAutores: Ali Shields, April W. Armstrong, Manraj N. Kaur, Alison M. Layton, Jerry Tan, John S. BarbieriLocalización: JAMA Dermatology, ISSN 2168-6068, Vol. 160, Nº. 1, 2024, págs. 88-92Idioma: inglésEnlacesTexto completoResumenImportance Treatment satisfaction is important to achieving therapeutic success in patients with inflammatory dermatological diseases, such as acne.
-
Nov 22, 2023 |
jamanetwork.com | Ali Shields |Drexel College |April W. Armstrong |Alison M. Layton
Key PointsQuestion Is the DermSat-7, a 7-item questionnaire specific for dermatological conditions, adequate for assessing treatment satisfaction in patients with acne? Findings In this cross-sectional study of 142 adults taking acne medication, the DermSat-7 had good structural validity and internal consistency for each of its 3 domains (effectiveness, convenience, and overall satisfaction).
-
Sep 8, 2023 |
mdedge.com | Ali Shields
A range of treatment options are available for both mild to moderate and moderate to severe acne, and these options vary widely in their clinical uses, effectiveness, and costs. With the continued rise of dermatologic drug prices and increased cost-sharing due to high-deductible health plans, the importance of cost-effective treatment continues to grow.
-
Sep 8, 2023 |
mdedge.com | Ali Shields |John S. Barbieri
In the United States, acne affects 85% of adolescents and can persist into adulthood at a prevalence of 30% to 50% in adult women. 1,2 The pathogenesis of acne is multifactorial and involves hyperkeratinization of the follicle, bacterial colonization with Cutibacterium acnes , and increased androgen-induced sebum production, which together lead to inflammation.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →